[2] Purification of receptors
David I. Schuster, Randall B. Murphy
Abstract
Open-access reader
David I. Schuster, Randall B. Murphy
Abstract
Open-access reader
This chapter discusses the experimental approaches that have been used successfully for purification of neurotransmitter receptors and other receptors of interest in neuroscience and behavior and the types of problems that are typically encountered in such studies. Purification of receptors for neurotransmitters, neuromodulators, opiates, drugs, and other chemical agents that act in the central nervous system, as well as the periphery, have become an essential step in molecular characterization of such receptors and facilitates elucidation of the biochemical and physiological events that take place on interaction of these agents with their binding sites. Based on pharmacological data, it is now clear that many neurotransmitter receptors exist as multiple subtypes, as in the case of dopamine (D1, D2, D3, D4, and D5 thus far) and serotonin (of which there are at least seven subtypes, e.g., 5HT1A, 5HT1B, and 5HT2), which differ markedly in their affinity for various receptor agonists and antagonists.
OpenAlex reports 2 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
This chapter discusses the experimental approaches that have been used successfully for purification of neurotransmitter receptors and other receptors of interest in neuroscience and behavior and the types of problems that are typically encountered in such studies. Purification of receptors for neurotransmitters, neuromodulators, opiates, drugs, and other chemical agents that act in the central nervous system, as well as the periphery, have become an essential step in molecular characterization of such receptors and facilitates elucidation of the biochemical and physiological events that take place on interaction of these agents with their binding sites. Based on pharmacological data, it is now clear that many neurotransmitter receptors exist as multiple subtypes, as in the case of dopamine (D1, D2, D3, D4, and D5 thus far) and serotonin (of which there are at least seven subtypes, e.g., 5HT1A, 5HT1B, and 5HT2), which differ markedly in their affinity for various receptor agonists and antagonists.
Key concepts: 5-HT2 receptor, Receptor, Neurotransmitter, 5-HT receptor, Serotonin, Neurotransmitter receptor, Class C GPCR, D2-like receptor